Expression and clinical significance of miR - 129 - 1 - 3p in serous ovarian cancer

Fei Liu,Li Yao,Jiarui Zhang,Pin Ren,Shumei Wang,Miao Lan,Wei Zhang,Yanhong Li
DOI: https://doi.org/10.3969/j.issn.1672-4992.2014.08.54
2014-01-01
Journal of Modern Oncology
Abstract:To detect the miR - 129 - 1 - 3p expression in the epithelial ovarian cancer and analyze the correlation of its expression with clinicopathonological features. Methods:Quantitative real - time PCR was employed to test the miR - 129 - 1 - 3p expression in 150 specimens(including 100 malignant serous epithelial ovarian cancer and 50 the normal fimbriated end of the distal fallopian tube). The relevance between the miR - 129 - 1 - 3p expres-sion and the pathoclinical characteristics was assessed. Results:The expression of miR - 129 - 1 - 3p was significant-ly down - regulated in patients with serous ovarian cancer compared to normal controls(P ﹤ 0. 01). Low expression of miR - 129 - 1 - 3p was not related to FIGO stage,age,pathologic differentiation,lymph node metastasis,and serum level of CA125(P ﹥ 0. 05). Conclusion:miR - 129 - 1 - 3p may participate the origination and progression of serous epithelial ovarian cancer as a tumor - supressor. It may represent potential indicator in the auxiliary of epithelial se-rous ovarian cancer and provide the theory basis to the biological targeted therapy of epithelial ovarian cancer.
What problem does this paper attempt to address?